Original Papers. Intensive Care Unit, Royal Perth Hospital, Perth, Western Australia, Australia
|
|
- Edgar Harmon
- 6 years ago
- Views:
Transcription
1 Anaesth Intensive Care 2008; 36: Original Papers Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis K. M. Ho*, D. J. Morgan Intensive Care Unit, Royal Perth Hospital, Perth, Western Australia, Australia Summary Acute renal dysfunction after radiocontrast in patients with pre-existing renal impairment is not uncommon and is associated with significant morbidity and mortality. Isotonic sodium bicarbonate solution was first reported to reduce radiocontrast nephropathy in This first study was, however, limited by its small sample size and as such, the use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy is still not widely used by many anaesthetists and intensivists. We meta-analysed relevant randomised controlled studies sourced from the Cochrane Controlled Trial Register (2007 issue 4), EMBASE and MEDLINE databases (1966 to April 15, 2008) without any language restriction. The use of isotonic sodium bicarbonate was associated with a significant reduction in risk of an incremental rise in serum creatinine concentration 25% above baseline (relative risk 0.22, 95% confidence interval [CI]: 0.11 to 0.44, P <0.0001; I 2 =0%) and had a protective effect on the absolute change in serum creatinine concentration (weighted-mean-difference -9.4 µmol/l, 95% CI: to -1.7, P=0.02; I 2 =0%) and creatinine clearance (weighted-mean-difference 3.7 ml/min, 95% CI: 0.55 to 6.80, P=0.02; I 2 =57.1%) after radiocontrast. The incidence of acute renal failure requiring dialysis was low (1.4%) and was not significantly different after the use of isotonic sodium bicarbonate (relative risk 0.59, 95% CI: 0.15 to 2.42, P=0.47; I 2 =0%). With the limited data available, isotonic sodium bicarbonate appears to be safe and very effective in reducing radiocontrast nephropathy in patients with mild pre-existing renal impairment. A large randomised controlled study is needed to confirm whether isotonic bicarbonate can improve patient centred clinical outcomes. Key Words: contrast, renal dysfunction, renal protection Radiocontrast nephropathy is the third leading cause of hospital-acquired renal failure, especially in patients with pre-existing renal impairment 1,2. Although radiocontrast nephropathy requiring dialysis is not common (0.7%) among those who receive radiocontrast, it is associated with significant morbidity and attributable mortality (>26%) 1. The mechanism of radiocontrast nephropathy is complex and may include direct toxic effect on cell proliferation and mitochondrial function, and * M.B., B.S., M.P.H., F.R.C.P., F.A.N.Z.C.A., F.J.F.I.C.M., Intensive Care Unit Consultant. M.B., B.S., F.A.C.E.M., F.J.F.I.C.M., Intensive Care Unit Consultant. Address for reprints: Dr K. M. Ho, Intensive Care Unit, Royal Perth Hospital, Perth, WA Accepted for publication on June 13, formation of free radicals in an acidic environment in the renal medulla resulting in vasoconstriction and ischaemia 2-4. Different pharmacological agents and procedures have been suggested to prevent radiocontrast nephropathy, including N-acetylcysteine, ascorbic acid, theophylline, fenoldopam, calcium antagonists and periprocedural haemofiltration with variable results 3. N-acetylcysteine is an antioxidant that can scavenge reactive oxygen species and regenerate glutathione stores and has been shown to attenuate radiocontrast nephropathy when administered before the onset of renal insult 5,6. However, N-acetylcysteine should ideally be commenced the night before the radiocontrast administration and hence this limits its utility mostly to elective radiocontrast-related procedures 7. Haemofiltration also appears to be effective in preventing radiocontrast nephropathy and can be commenced
2 a n d c o n t ra s t n e p h r o pat h y 647 during and after a procedure. It is, however, invasive and may not be cost effective in patients who are scheduled for simpler procedures 8. Intravenous sodium bicarbonate can alkalise the urine and may potentially reduce the formation of free radicals from radiocontrast in the renal medulla 9. Intravenous isotonic sodium bicarbonate was first reported to be effective in reducing radiocontrast nephropathy four years ago 9. In this study, isotonic sodium bicarbonate was started one hour before the radiocontrast-related procedure and was continued for six hours after the procedure. Because the isotonic sodium bicarbonate is started only one hour before the procedure, it is theoretically applicable to many patients including those who undergo emergency radiocontrast-related procedures. The original study which evaluated the effectiveness of isotonic sodium bicarbonate was, however, limited by its relatively small sample size and the low incidence of radiocontrast nephropathy. As such, many anaesthetists and intensivists have not adopted its use in preventing radiocontrast nephropathy. In this meta-analysis we assessed effectiveness of isotonic sodium bicarbonate in preventing radiocontrast nephropathy. MATERIALS AND METHODS Search strategy The literature search was performed on the Cochrane Controlled Trials Register (2007 issue 4), EMBASE (January 1990 to April 15, 2008) and MEDLINE databases (1966 to April 15, 2008). During the electronic database search, the following exploded MeSH terms were used: bicarbonate, alkalinization or alkaline with renal failure, renal dysfunction, dialysis, nephropathy or renal replacement therapy with contrast or radiocontrast. The initial search results were then limited to clinical trials, letters, editorial, reviews or randomised controlled trials only. The reference lists of related editorial, reviews and original articles identified were searched for relevant trials. Finally, the websites of International Network of Agencies of Health Technology Assessment and International Society of Technology Assessment in Health Care were searched to ensure all suitable trials were included. There were no language restrictions in this meta-analysis. Selection criteria and validity assessment Randomised controlled clinical trials, comparing sodium bicarbonate with either a placebo (e.g. no drug or 5% dextrose) or normal saline control, in patients who underwent a radiocontrast-related procedure were included. Studies comparing sodium bicarbonate with a placebo or normal saline and with equal co-interventions (e.g. N-acetylcysteine) in both arms were also included. There were no restrictions on timing of the intervention or population studied in this meta-analysis. However, studies evaluating the effects of sodium bicarbonate in sepsis or shock without the use of radiocontrast or studies that used unequal co-interventions (e.g. comparing N-acetylcysteine with sodium bicarbonate against a placebo or normal saline) were excluded. Two independent reviewers examined the full text of all identified trials to confirm that they fulfilled the inclusion criteria. They examined and recorded the trial characteristics and outcomes independently, using a pre-designed data abstraction form. This abstraction form was used to record information regarding the quality of the trial such as allocation concealment, randomisation method, blinding of treatment, intention-to-treat analysis, inclusion and exclusion criteria. The grading of allocation concealment was based on the Cochrane approach, that is, adequate or uncertain or inadequate. There were no disagreements between the two independent reviewers in the data extracted. Data were checked and entered into the Review Manager (version for Windows. Oxford, England: The Cochrane Collaboration, 2003) database for further analyses. Statistical analysis The proportion of patients with an incremental rise in serum creatinine concentration of greater than 25% above the baseline (or >0.50 mg/dl [44 µmol/l]) was chosen as the main outcomes of interest in this study. An incremental rise in serum creatinine concentrations of greater than 25% above the baseline was often used as a surrogate end-point in many studies on radiocontrast nephropathy because it is relatively common (10 to 15%) and also between 5% and 10% of those patients with an incremental rise in serum creatinine greater than 25% from baseline may eventually require dialysis 1,9. The other outcomes assessed included acute renal failure requiring dialysis, mortality, urinary ph after the administration of the isotonic sodium bicarbonate and absolute change in serum creatinine concentration and creatinine clearance (measured or estimated) from the baseline. The categorical outcomes were reported as relative risk (RR) with 95% confidence interval (CI), using a fixed effect model. The continuous outcomes were reported
3 648 K. M. Ho, D. J. Mo r ga n as a weighted-mean-difference (WMD) with 95% CI, also using a fixed effect model. If the mean and standard deviation of the continuous outcomes were not reported in the studies, we assigned the median as the mean and estimated standard deviation (SD) from the range (i.e. SD=range 0.95/4). The presence of heterogeneity between trials was assessed by the χ 2 statistics and the extent of inconsistency was assessed using I 2 statistics 10. An I 2 over 40% was regarded as having significant heterogeneity. All tests were two-tailed and a P value less than 0.05 was regarded as significant in this meta-analysis. If there were more than 10 studies identified, funnel plot would be used to assess publication bias 11. RESULTS Study description Four randomised controlled studies from four countries with a total of 573 adult patients with undergoing radiocontrast-related procedures were considered (Figure 1) 9, Three studies were excluded because they were not randomised controlled studies and one study was excluded because a combination of sodium bicarbonate and N-acetylcysteine was used to compare with normal saline control 18. The proportion of patients lost to follow-up was less than 10% in all studies but only two studies had adequate allocation concealment. None of the studies was blinded. Overall, there was a moderate risk of bias in the design of the pooled studies. Three studies involved patients with a baseline serum creatinine concentration above between 97 and 106 µml/l and one study looked at patients with a baseline serum creatinine concentration above 176 µmol/l 13. Two studies (338 patients) evaluated the effects of isotonic bicarbonate in patients undergoing a variety of radiocontrast-related procedures including vascular procedures and computed tomography 9,14, and the other two studies (235 patients) looked at only patients undergoing diagnostic or therapeutic cardiac catheterisation 12,13. Studies comparing isotonic sodium bicarbonate with a placebo or normal saline in preventing radiocontrast nephropathy in MEDLINE, EMBASE and Cochrane Controlled Trials Register Databases (n=400) Studies excluded in this meta-analysis - (n=396) - Studies not relevant or review articles (n=392) - Observational studies (n=3) Study used unequal co-intervention (n=1) 18 Studies suitable for detailed data extraction (n=4) Studies reported the post treatment urinary ph (n=3) Studies reported the proportion of patients with an incremental rise in serum creatinine concentration 25% above baseline (n=4) Studies reported the proportion of patients required dialysis (n=4) Studies reported the proportion of patients with mortality (n=1) Studies reported the changes in creatinine clearance and serum creatinine from baseline (n=3) Figure 1: Flow chart showing trial inclusion and exclusion in this meta-analysis.
4 a n d c o n t ra s t n e p h r o pat h y 649 Study, year, country Participants, inclusion and exclusion of origin Reference criteria Merten et al, 2004, 119 adult patients, with a serum USA 9 creatinine concentration >97.2 µmol/l but <707 µmol/l. Other exclusions included renal dialysis, multiple myeloma, pulmonary oedema, uncontrolled hypertension (systolic blood pressure >160 or diastolic blood pressure >100 mmhg), emergency catheterisation, exposure to radiocontrast within 2 weeks, allergy to the contrast and pregnancy. Masuda et al, 2007, 59 adult patients, with creatinine Japan 12 concentration >97 µmol/l. Exclusions included pre-existing dialysis, exposure to radiocontrast within 2 days before study, allergy to the contrast, pregnancy or planned administration of mannitol. Ozcan et al, 2005, 176 adult patients with creatinine Turkey 13 concentration >106 µmol/l but <352 µmol/l. Other exclusions included uncontrolled hypertension (systolic blood pressure > 160 and diastolic blood pressure >110 mmhg), emergency catheterisation, exposure to radiocontrast within 2 days of the study and volume overload. between 100 and 400 µmol/l [1.1 and 4.5 mg/ dl], undergoing elective open heart on-pump surgery. Patients with renal transplantation and chronic dialysis were excluded. Briguori et al, 2007, 219 adult patients, with pre-existing Italy 14 creatinine concentration >176 µml/l but <704 µmol/l. Other exclusions included pre-existing dialysis, multiple myeloma, pulmonary oedema, acute myocardial infarction, exposure to radiocontrast within 2 days of study and pregnancy. =sodium bicarbonate. Ta b l e 1 Characteristics of the included trials Interventions Outcomes Allocation concealment, blinding, intention to treat analysis group (n=60): IV 3 ml/kg/h of isotonic 1 hour before the procedure and then 1 ml/kg/h during and the procedure until 6 hours after the procedure. Control group (n=59): Same volume as in group. The solution was made of 154 mmol of sodium chloride in 5% dextrose. An incremental rise in serum creatinine concentration >25% above baseline, number of patients required dialysis, change in serum creatinine concentration, potassium concentration, urinary ph and creatinine clearance from the baseline. Allocation concealment adequate, unblinded, analysis not by intention to treat, loss to follow-up 7.3%. group (n=30): IV 3 ml/kg/h of isotonic 1 hour before the procedure and then 1 ml/kg/h during and the procedure until 6 hours after the procedure. Control group (n=29): Same volume as in group. The exact composition of the solution was not described. Mortality, an incremental rise in serum creatinine concentration >25% above baseline, number of patients required dialysis, change in serum creatinine concentration, urinary ph and creatinine clearance from the baseline. Allocation concealment adequate, unblinded, analysis not by intention to treat, loss to follow-up 3.3%. group (n=88): IV 1 ml/kg/h of isotonic 6 hours before the procedure and then 1 ml/kg/h during and the procedure until 6 hours after the procedure. Control group (n=88): Same volume as in group. The solution was made of 154 mmol/l of sodium chloride solution. BOTH groups also received oral N-acetylcysteine 600 mg twice a day started before the day before the procedure. Number of patients required dialysis, change in serum creatinine concentration and creatinine clearance from the baseline. Allocation concealment unclear, unblinded, analysis appeared to be by intention-to-treat. group (n=108): IV 3 ml/kg/h of isotonic 1 hour before the procedure and then 1 ml/kg/h during and the procedure until 6 hours after the procedure. Control group (n=111): Same volume as in group. The solution was made of 154 mmol/l of sodium chloride solution. BOTH groups also received oral N-acetylcysteine 1200 mg twice a day started before the day before the procedure. An incremental rise in serum creatinine concentration >25% above baseline, number of patients required dialysis, and change in serum potassium concentration and urinary ph from the baseline. Allocation concealment unclear, unblinded, analysis not by intention-to-treat, loss to followup 6.4%.
5 650 K. M. Ho, D. J. Mo r ga n Study Control WMD (fixed) Weight WMD (fixed) N M ean (SD) N M ean (SD) 95% CI % 95% CI Merten [9] (0.80) (0.60) [0.69, 1.11] Briguori [14] (0.90) (0.80) [0.77, 1.23] Masuda [12] (1.20) (0.90) [0.86, 1.94] Total (95% CI) [0.83, 1.13] Test for heterogeneity: Chi²=2.92, df=2 (P =0.23), I²=31.5% Test for overall effect: Z=13.04 (P < ) Favours NaCl Favours Figure 2: The effect of isotonic sodium bicarbonate on urinary ph. Study Control RR (fixed) Weight RR (fixed) n/n n/n 95% CI % 95% CI Merten [9] 1/60 8/ [0.02, 0.95] Briguori [14] 2/108 11/ [0.04, 0.82] Masuda [12] 2/30 10/ [0.05, 0.81] Ozcan [13] 4/88 12/ [0.11, 0.99] Total (95% CI) [0.11, 0.44] Total events: 9 (NaCO 3 ), 41 (Control) Test for heterogeneity: Chi²=0.95, df=3 (P =0.81), I²=0% Test for overall effect: Z=4.27 (P <0.0001) Favours Favours NaCl Figure 3: The effect of isotonic sodium bicarbonate on risk of an incremental rise in serum concentrations 25% above the baseline. Study Control WMD (fixed) Weight WMD (fixed) N M ean (SD) N Mean (SD) 95% CI % 95% CI Merten [9] (21.70) (17.00) [1.60, 15.60] Masuda [12] (20.90) (22.70) [-0.54, 21.74] Ozcan [13] (15.30) (8.69) [-2.12, 5.24] Total (95% CI) [0.55, 6.80] Test for heterogeneity: Chi²=4.66, df=2 (P =0.10), I²=57.1% Test for overall effect: Z=2.30 (P =0.02) Favours NaCl Favours Study Control WMD (fixed) Weight WMD (fixed) N M ean (SD) N M ean (SD) 95% CI % 95% CI Merten [9] (36.08) (24.64) [-20.76, 1.40] Masuda [12] (29.92) (36.08) [-35.42, -1.54] Ozcan [13] (51.92) (44.00) [-16.86, 11.58] Total (95% CI) [-17.20, -1.66] Test for heterogeneity: Chi²=1.97, df=2 (P =0.37), I²=0% Test for overall effect: Z=2.38 (P =0.02) Favours Favours NaCl Figure 5: The effect of sodium bicarbonate on changes in serum creatinine concentrations (µmol/l) from the baseline.
6 a n d c o n t ra s t n e p h r o pat h y 651 Study Control RR (fixed) Weight RR (fixed) n/n n/n 95% CI % 95% CI Merten [9] 0/60 0/59 Not estimable Briguori [14] 1/108 1/ [0.07, 16.22] Masuda [12] 1/30 3/ [0.04, 2.92] Ozcan [13] 1/88 1/ [0.06, 15.74] Total (95% CI) [0.15, 2.42] Total events: 3 (NaCO 3 ), 5 (Control) Test for heterogeneity: Chi²=0.58, df=2 (P =0.75), I²=0% Test for overall effect: Z=0.72 (P =0.47) Favours Favours NaCl Figure 6: The effect of isotonic sodium bicarbonate on risk of acute renal failure requiring dialysis. Two of the four included studies also used oral N-acetylcysteine (600 mg or 1200 mg) twice daily, started the day before the procedure, in both normal saline and isotonic sodium bicarbonate group 13,14. Two studies had adequate allocation concealment but blinding was not used in any of the studies 9,12. Three studies used the same isotonic sodium bicarbonate protocol (154 mmol of sodium bicarbonate in 154 ml added to 846 ml of 5% dextrose, 3 ml/kg/h for one hour before the procedure then 1 ml/kg/h during procedure and six hours after the procedure) 9,12,14 and the other study used similar isotonic sodium bicarbonate solution but started six hours before at 1 ml/kg/h and continued until six hours after the procedure 13. The detail characteristics of the included studies are described in Table 1. Effects of isotonic sodium bicarbonate on renal outcomes The use of isotonic sodium bicarbonate was associated with a significant increase in urinary ph (WMD 0.98, 95% CI: 0.83 to 1.13, P < , I 2 =31.5%) and a reduction in risk of an incremental rise in serum creatinine concentration 25% above baseline (RR 0.22, 95% CI: 0.11 to 0.44, P <0.0001; I 2 =0%) (Figures 2 and 3). It also had a protective effect on the absolute change in serum creatinine concentration (WMD -9.4 µmol/l, 95% CI: to -1.7, P=0.02; I 2 =0%) and creatinine clearance (WMD 3.7 ml/min, 95% CI: 0.55 to 6.80, P=0.02; I 2 =57.1%) from the baseline after the use of radiocontrast (Figures 4 and 5). The incidence of acute renal failure requiring dialysis was low (1.4%) and was not significantly different after the use of isotonic sodium bicarbonate (RR 0.59, 95% CI: 0.15 to 2.42, P=0.47; I 2 =0%). % CI: 0.58 to 1.92) (Figure 6). There was significant heterogeneity only in the change in creatinine clearance from the baseline between the pooled studies. Significant treatment-related adverse effect was observed in only one patient during the bolus infusion of isotonic sodium bicarbonate in the four pooled studies 9. Two studies reported on the changes in serum potassium concentration after the treatment of isotonic sodium bicarbonate solution and did not find a significant difference 9,14. Mortality was reported in one study and there was no significant difference between patients who received isotonic sodium bicarbonate or normal saline (RR 0.18, 95% CI: 0.01 to 3.92, P=0.28) but the total length of hospital stay was not reported in any of the pooled studies 12. Funnel plot was not performed because of the small number of studies included in this meta-analysis. DISCUSSION This meta-analysis shows that isotonic sodium bicarbonate is effective in increasing urinary ph and reducing a rise in serum creatinine concentrations after radiocontrast in patients with mild pre-existing renal impairment. There is, however, a lack of patientcentred outcome data because of the small number of patients included in this meta-analysis. Our results showed that isotonic sodium bicarbonate is effective in reducing a rise in serum creatinine after radiocontrast. This conclusion was different from the results of a recent retrospective observational study in which sodium bicarbonate was not associated with an improved renal outcome. Observational studies can, however, be affected by undetected bias and confounding. The moderate quality and consistency of results of the pooled randomised controlled studies suggest that sodium bicarbonate is more likely to be effective than normal saline in reducing radiocontrast nephropathy. Sodium bicarbonate is inexpensive and would be potentially very cost-effective if it could prevent acute renal dysfunction or failure after radiocontrast. Also,
7 652 K. M. Ho, D. J. Mo r ga n because sodium bicarbonate can be administered in a diluted form as an isotonic solution, central vascular access is not necessary, making it a very attractive alternative option when compared to other drugs or procedures such as haemofiltration. Furthermore, isotonic sodium bicarbonate can be administered 60 minutes before the administration of radiocontrast, and as such, its role in emergency radiocontrast-related procedures is likely to be more important than N-acetylcysteine. Finally, two of the pooled studies evaluated the combination of isotonic sodium bicarbonate with N-acetylcysteine, and from their results it appears that isotonic sodium bicarbonate can offer additional protective benefits in reducing radiocontrast nephropathy. It also appears that the magnitude of protection offered by isotonic sodium bicarbonate solution in preventing an incremental rise in serum creatinine concentrations 25% above baseline is similar to high dose N-acetylcysteine (1200 mg twice a day for two days) (RR 0.22 vs. 0.24) 6. The mechanism by which sodium bicarbonate can prevent radiocontrast nephropathy remains uncertain. It has been postulated that free radical formation is promoted by an acidic environment and inhibited by a higher ph in the urine 9. Our results confirmed that infusing a relatively small dose of isotonic sodium bicarbonate solution over seven to 12 hours can increase the urinary ph from around 5.5 to between 6 and 7. While N-acetylcysteine works as a free radical scavenger, isotonic sodium bicarbonate works by reducing the formation of free radicals by inducing an alkaline environment in the renal tubules in preventing radiocontrast nephropathy and, as such, it is highly possible that they can have additional protective effect on radiocontrast nephropathy. This small dose of isotonic sodium bicarbonate appears to be fairly safe, the only adverse event reported being a transient increase in blood pressure during the bolus infusion (3 ml/kg/h) 9. Although hypokalaemia was not found to be a significant problem in two pooled studies, it is still possible for isotonic sodium bicarbonate to induce hypokalaemia and cardiac arrhythmias in some susceptible patients. This meta-analysis has significant limitations. First, as with any overview, meta-analysis is prone to bias. In order to avoid selection bias, we have searched studies from three databases without language restrictions. Second, there was significant heterogeneity in the continuous outcomes in the pooled studies. This is likely due to different patient characteristics in different cohorts and also most studies estimated the creatinine clearance by Cockcroft-Gault equation which may not be reliable in critically ill hospitalised patients 19 and, as such, the pooled mean estimate of these continuous outcomes should be interpreted with caution and is not generalisable. Third, although isotonic sodium bicarbonate has a protective effect on the risk of an incremental rise in serum creatinine concentration greater than 25% above the baseline, other important patient-centred outcomes such as risk of mortality and dialysis were not significantly altered by the use of isotonic sodium bicarbonate. In this regard, we cannot exclude a type II error because of the small sample size of this meta-analysis (n=573). Because the incidence of acute renal failure requiring dialysis from radiocontrast nephropathy is low (1.4% overall), a sample size of 2400 patients will be needed to achieve a power of 80% to confirm a 70% relative risk reduction in acute renal failure requiring dialysis (from 1.7% to 0.5%) after the use of isotonic sodium bicarbonate. Finally, length of hospital stay is important in cost-effective analysis of any new treatments, but none of the studies reported this important clinical outcome. A large randomised controlled study is therefore needed to confirm the effects of isotonic sodium bicarbonate on important patient-centred outcomes and its cost effectiveness in patients with pre-existing renal impairment who undergo radiocontrast-related procedures. References 1. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 52: Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98:14K-20K. 3. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006; 113: Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 2001; 280:F Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: Sinert R, Doty CI. Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department. Ann Emerg Med 2007; 50: Klarenbach SW, Pannu N, Tonelli MA, Manns BJ. Costeffectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med 2006; 34:
8 a n d c o n t ra s t n e p h r o pat h y Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 2005; 58: Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007; 100: Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 2007; 154: Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115: Hoshino A, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Nakamura T. Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents. J Cardiol 2007; 50: Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrastinduced nephropathy following coronary angiography. Ann Pharmacother 2007; 41: From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol 2008; 3: Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 2007; 49: Poggio ED, Nef PC, Wang X, Greene T, Van Lente F, Dennis VW et al. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005; 46:
Contrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More information16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA?
16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA? Dott. Andrea Boccatonda Università degli Studi G. d Annunzio Chieti Chi di voi non ha mai discusso con un radiologo per eseguire
More informationMortality Associated With Nephropathy After Radiographic Contrast Exposure
ORIGINAL ARTICLE MORTALITY ASSOCIATED WITH NEPHROPATHY AFTER RADIOGRAPHIC CONTRAST EXPOSURE Mortality Associated With Nephropathy After Radiographic Contrast Exposure AARON M. FROM, MD; BRIAN J. BARTHOLMAI,
More informationN-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies
RESEARCH REPORT N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies Hossein Khalili, Simin Dashti-Khavidaki, Hamed Tabifar, Nasrin
More informationSAFETY IN THE CATH LAB How to Minimise Contrast Toxicity
SAFETY IN THE CATH LAB How to Minimise Contrast Toxicity Dr. Vijay Kunadian MBBS, MD, MRCP Senior Lecturer and Consultant Interventional Cardiologist Institute of Cellular Medicine, Faculty of Medical
More informationDoreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing
Doreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing This program has been developed solely for the purposes of describing the level of nurse practitioner (NP)
More informationPrevention of Contrast induced Nephropathy
55 th Annual Scientific Meeting of The Korean Society of Cardiology 11:50 12:10 Message from Nephrologists Dec 03, 2011 Prevention of Contrast induced Nephropathy Soo Wan Kim, MD, PhD Department of Internal
More informationSofia Fayngold CRC Rotation IRB proposal 9/1/2011
Sofia Fayngold CRC Rotation IRB proposal 9/1/2011 Sodium Bicarbonate Hydration for the Prevention of Contrast Induced Nephropathy following Computed Tomography Angiography of the Chest for Pulmonary Emoblism
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More information618 meta-analyses have shown inconsistent results on the efficacy of N-acetylcysteine for the prevention of contrast-induced nephropathy because some
Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis Sankar D. Navaneethan, MD, MPH, 1 Sonal Singh, MD, MPH, 2 Suresh Appasamy, MD, 3 Richard
More informationA New Protocol Using Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
A New Protocol Using Sodium for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography Masayuki Motohiro, MD a, *, Hiroshi Kamihata, MD b, Satoshi Tsujimoto, MD b, Takeshi
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives
Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors
Cardiovascular Risk Factors ROB WALKER (Dunedin, New Zealand) Lipid-lowering therapy in patients with chronic kidney disease Date written: January 2005 Final submission: August 2005 Author: Rob Walker
More informationContrast-Induced Nephropathy: Evidenced Based Prevention
Contrast-Induced Nephropathy: Evidenced Based Prevention Michael J Cowley, MD, FSCAI Nothing to disclose Contrast-Induced Nephropathy (CIN) Definitions New onset or worsening of renal function after contrast
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil
Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard
More informationof developing contrast -induced
Original Article Singapore Med 1 2009, 50 (3) : 250 Diabetic patients with normal baseline renal function are at increased risk of developing contrast -induced nephropathy post-percutaneous coronary intervention
More informationMinimizing the Renal Toxicity of Iodinated Contrast
Minimizing the Renal Toxicity of Iodinated Contrast Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Chief Academic and Scientific Officer St. John Providence Health System Detroit, MI USA Outline
More informationThe PRESERVE trial: does it guide prevention strategies for post angiography acute kidney injury?
Editorial Page 1 of 7 The PRESERVE trial: does it guide prevention strategies for post angiography acute kidney injury? Richard Solomon Larner College of Medicine, University of Vermont, Burlington, VT,
More informationEvaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity
ISPUB.COM The Internet Journal of Internal Medicine Volume 6 Number 1 Evaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationFollow-up of patients with contrast-induced nephropathy
http://www.kidney-international.org & 2006 International Society of Nephrology Follow-up of patients with contrast-induced nephropathy R Solomon 1 and B Barrett 2 1 Fletcher Allen Health Care, University
More informationContrast-induced acute kidney injury (CI-AKI) is probably
Sodium Bicarbonate for the Prevention of Contrast Induced- Acute Kidney Injury: A Systematic Review and Meta-analysis Somjot S. Brar,* Swapnil Hiremath, George Dangas,* Roxana Mehran,* Simerjeet K. Brar,*
More informationAdvance Publication by J-STAGE
Sodium Bicarbonate Improves Long-Term Clinical Outcomes Compared With Sodium Chloride in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure Masaharu Masuda, MD; Takahisa Yamada,
More informationContrast-induced nephropathy
Acute kidney injury with iodinated contrast Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Diagnostic and interventional radiographic procedures in critically ill patients commonly depend on iodinated
More informationCONTRAST-INDUCED NEPHROPATHY Y HỌC CHỨNG CỨ VÀ BIỆN PHÁP DỰ PHÒNG
CONTRAST-INDUCED NEPHROPATHY Y HỌC CHỨNG CỨ VÀ BIỆN PHÁP DỰ PHÒNG DEFINITION Reversible form of acute kidney injury that occurs soon after the administration of radiocontrast media. PATHOGENESIS RISK FACTORS
More informationThe Incidence Of Contrast-Induced Nephropathy Or Radiocontrast Nephropathy
ISPUB.COM The Internet Journal of Radiology Volume 18 Number 1 The Incidence Of Contrast-Induced Nephropathy Or Radiocontrast Nephropathy K O Kragha Citation K O Kragha. The Incidence Of Contrast-Induced
More informationSupplementary Online Content
Supplementary Online Content Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic
More informationPreventing Nephropathy Induced by Contrast Medium
T h e n e w e ng l a nd j o u r na l of m e dic i n e Preventing Nephropathy Induced by Contrast Medium Brendan J. Barrett, M.B., and Patrick S. Parfrey, M.D. This Journal feature begins with a case vignette
More informationThe Prevention of Radiocontrast-Agent Induced Nephropathy by Hemofiltration
The new england journal of medicine original article The Prevention of Radiocontrast-Agent Induced Nephropathy by Hemofiltration Giancarlo Marenzi, M.D., Ivana Marana, M.D., Gianfranco Lauri, M.D., Emilio
More informationCATH LAB SYMPOSIUM 2010
CATH LAB SYMPOSIUM 2010 Low resistance system High Pressure in Capillaries to filter plasma RBF: 1.2-1.3 L/min (25% of C.O.) Low AV difference ( shunt ) Kidney: 14 ml O2/L blood Brain: 62 ml O2/L blood
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES
Specific management of IgA nephropathy: role of steroid therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Steroid therapy may protect against progressive
More informationMeta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014
Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity
More informationSection 4. CONTRAST INDUCED ACUTE KIDNEY INJURY
Section 4. CONTRAST INDUCED ACUTE KIDNEY INJURY Authors: Martin Gallagher, Vincent D Intini GUIDELINES a. We recommend using either iso-osmolar or low-osmolar iodinated contrast media, rather than high-osmolar
More informationData extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.
Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives
More informationStandard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
European Heart Journal (2004) 25, 206 211 Clinical research Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Carlo Briguori a,b *, Antonio Colombo b, Anna
More informationPrevention of Contrast Induced Acute Kidney Injury (CI-AKI) In Adult Patients. on behalf of
Prevention of Contrast Induced Acute Kidney Injury (CI-AKI) In Adult Patients on behalf of The Renal Association, British Cardiovascular Intervention Society and The Royal College of Radiologists Dr Andrew
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationA Paradigm Shift in Contrast-Induced Acute Kidney Injury (CI-AKI) Prevention
CE Mark US: Investigational device. Limited by Federal Law to investigational use only. A Paradigm Shift in Contrast-Induced Acute Kidney Injury (CI-AKI) Prevention 1 ED00092 Rev. A Clinical Problem 2
More informationUpdate in Nephrology. Case: Question 1. Case presentation. Acute Kidney Injury. For her hypertension management, you decide to:
Update in Nephrology Chronic Kidney Disease Renoprotection and Proteinuria, ACE and/or ARB Anemia management Update in Nephrology Renal artery stenosis Nephrogenic systemic fibrosis Division of Nephrology
More informationPrevention of Contrast-Induced Nephropathy in the Emergency Department
EVIDENCE-BASED EMERGENCY MEDIE REVIEW Prevention of Contrast-Induced Nephropathy in the Emergency Department Richard Sinert, DO Christopher I. Doty, MD From the Department of Emergency Medicine, State
More informationPrevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence
Prevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence Swapnil Hiremath 1,2 *, Ayub Akbari 1,2, Wael Shabana 3, Dean A.
More informationCT and Contrast-Induced Nephrophathy (CIN)
CT and Contrast-Induced Nephrophathy (CIN) Philipp A Kaufmann, MD Professor and Director of Cardiac Imaging University Hospital Zurich, Switzerland DISCLOSURE: Institutional Research contract with GE CIN
More informationComparison of Three Whole Blood Creatinine Methods for Estimation of Glomerular Filtration Rate Before Radiographic Contrast Administration
Clinical Chemistry / Whole Blood Creatinine for egfr Comparison of Three Whole Blood Creatinine Methods for Estimation of Glomerular Filtration Rate Before Radiographic Contrast Administration Nichole
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationPrevention of Acute Renal Failure Role of vasoactive drugs and diuretic agents
of Acute Renal Failure Role of vasoactive drugs and diuretic agents Armand R.J. Girbes Prof.dr. A.R.J. Girbes Chairman department of Intensive Care VU University Medical Center Netherlands (Failure of)
More informationAKI-6 Epidemiology of Acute Kidney Injury
FACULTY OF MEDICINE AND HEALTH SCIENCES Academic Year 2011-2012 AKI-6 Epidemiology of Acute Kidney Injury Anne NOBELS Promotor: Prof. Dr. E. Hoste Co-promotor: Prof. Dr. J. Kellum (Pittsburg) Dissertation
More information11.1 Supplemental Antioxidant Nutrients: Combined Vitamins and Trace Elements April 2013
. Supplemental Antioxidant Nutrients: Combined Vitamins and Trace Elements April 23 23 Recommendation: Based on 7 level and 7 level 2 studies, the use of supplemental combined vitamins and trace elements
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment
Specific management of IgA nephropathy: role of triple therapy and cytotoxic therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. Triple therapy with cyclophosphamide,
More informationDatabase of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown
More informationDeep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
More informationStudy population The study population comprised a hypothetical cohort of patients with severe sepsis and septic shock.
Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock Neilson A R, Burchardi H, Schneider H Record Status This is a critical abstract
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationContrast-induced nephropathy (CIN), which is the development
Annals of Internal Medicine Review Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy Sophia Zoungas, MD, PhD; Toshiharu Ninomiya, MD, PhD; Rachel
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationAcute Kidney Injury in the ED
+ Acute Kidney Injury in the ED + Dr Eric Clark, MD FRCPC University of Ottawa Canada Canadian Association of Emergency Physicians + Outline 1. Diagnostic challenges 2. ED treatment 3. Contrast induced
More informationRACE611 CLINICAL EPIDEMIOLOGY AND EVIDENCE-BASED MEDICINE Theraputic study
RACE611 CLINICAL EPIDEMIOLOGY AND EVIDENCE-BASED MEDICINE Theraputic study Master of Science Program in Medical Epidemiology and Doctor of Philosophy Program in Clinical Epidemiology Section for Clinical
More informationPrevention of Contrast Induced Nephropathy (CIN) Guidelines
Prevention of Contrast Induced Nephropathy (CIN) Guidelines This procedural document supersedes: PAT/T 48 v.1 - Guidelines for Prevention of Contrast Induced Nephropathy (CIN) Did you print this document
More informationThe Placebo Attributable Fraction in General Medicine: Protocol for a metaepidemiological
Fixed and uploaded on September 4, 2018 The Placebo Attributable Fraction in General Medicine: Protocol for a metaepidemiological Study of Cochrane Reviews Yusuke Tsutsumi1, 2, Yasushi Tsujimoto1, 3, Aran
More informationThe RENO Study. Objectives. Background. Methods. Results. Conclusions
Journal of the American College of Cardiology Vol. 49, No. 12, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.11.034
More informationOutcomes assessed in the review
The effectiveness of mechanical compression devices in attaining hemostasis after removal of a femoral sheath following femoral artery cannulation for cardiac interventional procedures Jones T Authors'
More informationContrast-induced acute kidney injury (CI-AKI) is a powerful
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II) RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury Carlo Briguori, MD, PhD; Gabriella Visconti,
More informationA Rapid Protocol for the Prevention of Contrast- Induced Renal Dysfunction: The RAPPID Study
Journal of the American College of Cardiology Vol. 41, No. 12, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00487-x
More informationCorrespondence should be addressed to Lantam Sonhaye;
Radiology Research and Practice Volume 2015, Article ID 805786, 4 pages http://dx.doi.org/10.1155/2015/805786 Research Article Intravenous Contrast Medium Administration for Computed Tomography Scan in
More informationPersistent Renal Damage After Contrast-Induced Acute Kidney Injury Incidence, Evolution, Risk Factors, and Prognosis
Persistent Renal Damage After Contrast-Induced Acute Kidney Injury Incidence, Evolution, Risk Factors, and Prognosis Mauro Maioli, MD; Anna Toso, MD; Mario Leoncini, MD; Michela Gallopin, MD; Nicola Musilli,
More informationCritical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto
Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death Debra Moy Faculty of Pharmacy University of Toronto Goal To provide practitioners with a systematic approach to evaluating a meta analysis
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationMeta-analyses: analyses:
Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific
More informationJin Wi, 1 Young-Guk Ko, 1 Jung-Sun Kim, 1 Byeong-Keuk Kim, 1 Donghoon Choi, 1 Jong-Won Ha, 1 Myeong-Ki Hong, 1,2 Yangsoo Jang 1,2 ORIGINAL ARTICLE
See Editorial, p 1723 1 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea 2 Severance Biomedical Science Institute, Yonsei University
More informationOut of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence)
Membranous nephropathy role of cyclosporine therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. The use of cyclosporine therapy alone to prevent progressive
More informationRenal Protection Staying on Target
Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary
More informationAngiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease
Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease Investigator Meeting 12 th September 2017 - Sheffield Prof Sunil Bhandari Consultant
More informationAcute Kidney Injury. Amandeep Khurana, MD Southwest Kidney Institute
Acute Kidney Injury Amandeep Khurana, MD Southwest Kidney Institute 66 yr white male w/ DM, HTN, CAD admitted to an OSH w/ E Coli UTI on 7/24/16, developed E Coli bacteremia and Shock (on vaso + levo)
More informationContrast nephropathy: can we see the whole picture
Contrast nephropathy: can we see the whole picture Raff M, MSc(Wits), MBChB(Pret), FFA(SA) Correspondence to: Dr Milton Raff, e-mail: raffs@iafrica.com Introduction Renal protection has remained a highly
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationUltrafiltration in Decompensated Heart Failure. Description
Subject: Ultrafiltration in Decompensated Heart Failure Page: 1 of 7 Last Review Status/Date: September 2016 Ultrafiltration in Decompensated Heart Failure Description Ultrafiltration is a technique being
More informationAcute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis
Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? A common condition in ICU patients Associated with high mortality and morbidity Renal Replacement Therapy (RRT) is the cornerstone
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Weisbord SD, Gallagher M, Jneid H, et al. Outcomes after angiography
More informationStRs and CT doctors in haematology. September Folinic acid dose modified.
High dose Methotrexate and folinic acid rescue Full Title of Guideline: Author (include email and role): Division & Speciality: Clinical Guideline Review Date September 2018 GUIDELINE FOR THE USE OF HIGH
More informationInitiation Strategies for Renal Replacement Therapy in ICU
Initiation Strategies for Renal Replacement Therapy in ICU The Artificial Kidney Initiation in Kidney Injury trial AKIKI Stéphane Gaudry Réanimation médico-chirurgicale Hôpital Louis Mourier, Colombes
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationUniversity of Groningen. Acute kidney injury after cardiac surgery Loef, Berthus Gerard
University of Groningen Acute kidney injury after cardiac surgery Loef, Berthus Gerard IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationDeterminants of quality: Factors that lower or increase the quality of evidence
Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors
More informationThe Incidence of Contrast Induced Nephropathy in Trauma Patients.
The Incidence of Contrast Induced Nephropathy in Trauma Patients. Item Type Thesis Authors Cordeiro, Samuel Publisher The University of Arizona. Rights Copyright is held by the author. Digital access to
More informationCardiac Catheterization
Cardiac Catheterization Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography A Systematic Review and Meta-Analysis Matthew T. James, MD, PhD; Susan M. Samuel,
More information8.0 Parenteral Nutrition vs. Standard care May 2015
8.0 Parenteral Nutrition vs. Standard care May 015 015 Recommendation: Based on 6 level studies, in critically ill patients with an intact gastrointestinal tract, we recommend that parenteral nutrition
More informationCisplatin and Gemcitabine Bladder Cancer: Full and split dose
Systemic Anti Cancer Treatment Protocol Cisplatin and Gemcitabine Bladder Cancer: Full and split dose PROCTOCOL REF: MPHAUROCIG (Version No: 1.0) Approved for use in: Neoadjuvant and palliative indications
More informationAcute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
More informationNirmal Singh, 1 Justin Z Lee, 2 Jennifer J Huang, 2 See Wei Low, 1 Carol Howe, 3 Anil Pandit, 4 Prakash Suryanarayana, 1 Kwan S Lee 1.
To cite: Singh N, Lee JZ, Huang JJ, et al. Benefit of statin pretreatment in prevention of contrastinduced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart
More informationHydration with Sodium Bicarbonate Does Not Prevent Contrast Nephropathy: A Multicenter Clinical Trial
Hydration with Sodium Bicarbonate Does Not Prevent Contrast Nephropathy: A Multicenter Clinical Trial Vitor O. Gomes 1,7, Ricardo Lasevitch 1, Valter C. Lima 2, Fábio S. Brito Jr. 3, Juan Carlos Perez-Alva
More informationSurveillance report Published: 17 March 2016 nice.org.uk
Surveillance report 2016 Ovarian Cancer (2011) NICE guideline CG122 Surveillance report Published: 17 March 2016 nice.org.uk NICE 2016. All rights reserved. Contents Surveillance decision... 3 Reason for
More informationSupplemental Material. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present
Supplemental Material Supplemental Appendix : Search Strategy Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 96 to Present. exp Contrast Media/ 907. exp Kidney Diseases/ 8.
More informationVasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada
Vasopressors in Septic Shock Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada Echocardiogram: EF=25% 57 y.o. female, pneumonia, shock Echocardiogram: EF=25% 57 y.o.
More informationSupplementary Online Content
Supplementary Online Content Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Biochemical Targets. Calcium GUIDELINES
Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Biochemical Targets CARMEL HAWLEY (Woolloongabba, Queensland) GRAHAME ELDER (Westmead, New South Wales) Calcium GUIDELINES
More informationEvidence Table. Study Type: Randomized controlled trial. Study Aim: To compare frequent nocturnal hemodialysis and conventional in-center dialysis.
Evidence Table Clinical Area: Reference: Frequent home dialysis Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass
More informationDATE: 04 April 2012 CONTEXT AND POLICY ISSUES
TITLE: Procedure Site Bleeding Complications Following Percutaneous Coronary Interventions or Angioplasty: A Review of Clinical Evidence and Guidelines DATE: 04 April 2012 CONTEXT AND POLICY ISSUES Percutaneous
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More information